361 related articles for article (PubMed ID: 16372880)
1. Vaccine development for non-typeable Haemophilus influenzae and Moraxella catarrhalis: progress and challenges.
Murphy TF
Expert Rev Vaccines; 2005 Dec; 4(6):843-53. PubMed ID: 16372880
[TBL] [Abstract][Full Text] [Related]
2. New vaccines against otitis media: projected benefits and cost-effectiveness.
O'Brien MA; Prosser LA; Paradise JL; Ray GT; Kulldorff M; Kurs-Lasky M; Hinrichsen VL; Mehta J; Colborn DK; Lieu TA
Pediatrics; 2009 Jun; 123(6):1452-63. PubMed ID: 19482754
[TBL] [Abstract][Full Text] [Related]
3. Current progress with Moraxella catarrhalis antigens as vaccine candidates.
Mawas F; Ho MM; Corbel MJ
Expert Rev Vaccines; 2009 Jan; 8(1):77-90. PubMed ID: 19093775
[TBL] [Abstract][Full Text] [Related]
4. Vaccines for Moraxella catarrhalis and non-typeable Haemophilus influenzae.
McMichael JC; Green BA
Curr Opin Investig Drugs; 2003 Aug; 4(8):953-8. PubMed ID: 14508879
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in otitis media. 6. Vaccine.
Giebink GS; Kurono Y; Bakaletz LO; Kyd JM; Barenkamp SJ; Murphy TF; Green B; Ogra PL; Gu XX; Patel JA; Heikkinen T; Pelton SI; Hotomi M; Karma P
Ann Otol Rhinol Laryngol Suppl; 2005 Jan; 194():86-103. PubMed ID: 15700938
[No Abstract] [Full Text] [Related]
6. Upper respiratory tract bacterial carriage in Aboriginal and non-Aboriginal children in a semi-arid area of Western Australia.
Watson K; Carville K; Bowman J; Jacoby P; Riley TV; Leach AJ; Lehmann D;
Pediatr Infect Dis J; 2006 Sep; 25(9):782-90. PubMed ID: 16940834
[TBL] [Abstract][Full Text] [Related]
7. The promise of immunoprophylaxis for prevention of acute otitis media.
Pelton SI; Klein JO
Pediatr Infect Dis J; 1999 Oct; 18(10):926-35. PubMed ID: 10530593
[No Abstract] [Full Text] [Related]
8. Effect of Pneumococcal Conjugate Vaccine on the Natural Antibodies and Antibody Responses Against Protein Antigens From Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in Children With Community-acquired Pneumonia.
Andrade DC; Borges IC; Adrian PV; Meinke A; Barral A; Ruuskanen O; Käyhty H; Nascimento-Carvalho CM
Pediatr Infect Dis J; 2016 Jun; 35(6):683-9. PubMed ID: 26954601
[TBL] [Abstract][Full Text] [Related]
9. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.
Harrison CJ; Woods C; Stout G; Martin B; Selvarangan R
J Antimicrob Chemother; 2009 Mar; 63(3):511-9. PubMed ID: 19174454
[TBL] [Abstract][Full Text] [Related]
10. Moraxella catarrhalis, a human respiratory tract pathogen.
Murphy TF; Parameswaran GI
Clin Infect Dis; 2009 Jul; 49(1):124-31. PubMed ID: 19480579
[TBL] [Abstract][Full Text] [Related]
11. Vaccine targets against Moraxella catarrhalis.
Ren D; Pichichero ME
Expert Opin Ther Targets; 2016; 20(1):19-33. PubMed ID: 26565427
[TBL] [Abstract][Full Text] [Related]
12. Update on non-typeable Haemophilus influenzae-mediated disease and vaccine development.
Jalalvand F; Riesbeck K
Expert Rev Vaccines; 2018 Jun; 17(6):503-512. PubMed ID: 29863956
[TBL] [Abstract][Full Text] [Related]
13. A fluorescent multiplexed bead-based immunoassay (FMIA) for quantitation of IgG against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis protein antigens.
Andrade DC; Borges IC; Laitinen H; Ekström N; Adrian PV; Meinke A; Barral A; Nascimento-Carvalho CM; Käyhty H
J Immunol Methods; 2014 Mar; 405():130-43. PubMed ID: 24530690
[TBL] [Abstract][Full Text] [Related]
14. Vaccines for Nontypeable Haemophilus influenzae: the Future Is Now.
Murphy TF
Clin Vaccine Immunol; 2015 May; 22(5):459-66. PubMed ID: 25787137
[TBL] [Abstract][Full Text] [Related]
15. Seasonal distribution of otitis media pathogens among Costa Rican children.
Guevara S; Soley C; Arguedas A; Porat N; Dagan R
Pediatr Infect Dis J; 2008 Jan; 27(1):12-6. PubMed ID: 18162931
[TBL] [Abstract][Full Text] [Related]
16. Current progress of adhesins as vaccine candidates for Moraxella catarrhalis.
Tan TT; Riesbeck K
Expert Rev Vaccines; 2007 Dec; 6(6):949-56. PubMed ID: 18377357
[TBL] [Abstract][Full Text] [Related]
17. Nontypeable Haemophilus influenzae as a pathogen in children.
Murphy TF; Faden H; Bakaletz LO; Kyd JM; Forsgren A; Campos J; Virji M; Pelton SI
Pediatr Infect Dis J; 2009 Jan; 28(1):43-8. PubMed ID: 19057458
[TBL] [Abstract][Full Text] [Related]
18. Monophosphoryl lipid A induced innate immune responses via TLR4 to enhance clearance of nontypeable Haemophilus influenzae and Moraxella catarrhalis from the nasopharynx in mice.
Hirano T; Kodama S; Kawano T; Maeda K; Suzuki M
FEMS Immunol Med Microbiol; 2011 Dec; 63(3):407-17. PubMed ID: 22092567
[TBL] [Abstract][Full Text] [Related]
19. Protein D of Haemophilus influenzae: a protective nontypeable H. influenzae antigen and a carrier for pneumococcal conjugate vaccines.
Forsgren A; Riesbeck K; Janson H
Clin Infect Dis; 2008 Mar; 46(5):726-31. PubMed ID: 18230042
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of culture and polymerase chain reaction methods for the detection of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis in cerebrospinal fluids and middle ear effusions].
Jbara I; Baysallar M; Kiliç A; Yetişer S; Unay B; Açikel C; Yapar M; Doğanci L
Mikrobiyol Bul; 2007 Oct; 41(4):495-502. PubMed ID: 18173067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
